Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 488

1.
2.

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.

Ann Intern Med. 1998 Jun 15;128(12 Pt 1):982-8.

PMID:
9625684
3.
4.
5.

Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II.

Ravid M, Savin H, Jutrin I, Bental T, Lang R, Lishner M.

Kidney Int Suppl. 1994 Feb;45:S161-4.

PMID:
8158887
7.

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.

Arch Intern Med. 1998 May 11;158(9):998-1004.

PMID:
9588433
8.

Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study.

Sano T, Hotta N, Kawamura T, Matsumae H, Chaya S, Sasaki H, Nakayama M, Hara T, Matsuo S, Sakamoto N.

Diabet Med. 1996 Feb;13(2):120-4.

PMID:
8641115
9.

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

Diabetes Care. 1998 Jan;21(1):104-10.

PMID:
9538979
11.
12.

[Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].

Durruty P, Tapia JC, Ugarte C, Pérez E, Krause P, Soto N, García de los Ríos M.

Rev Med Chil. 1996 Sep;124(9):1036-44. Spanish.

PMID:
9197016
13.

Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.

Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM.

BMJ. 1994 Dec 17;309(6969):1608-12.

14.

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.

PMID:
15799209
15.

Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.

Ciavarella A, Mustacchio A, Silletti A, Franchi R, Levorato M, Campieri C, Borgnino LC, Capozzi G, Morotti L, Vannini P.

Eur J Med. 1992 Sep;1(5):268-72.

PMID:
1341608
17.

Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.

Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C; Melbourne Diabetic Nephropathy Study Group.

Diabet Med. 2004 Nov;21(11):1192-9.

PMID:
15498085
18.

Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria.

de Mello VD, Zelmanovitz T, Azevedo MJ, de Paula TP, Gross JL.

J Ren Nutr. 2008 Sep;18(5):440-7. doi: 10.1053/j.jrn.2008.04.010.

PMID:
18721739
19.

Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.

Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M.

BMJ. 1993 Jan 16;306(6871):175-82.

20.

Supplemental Content

Support Center